You have 9 free searches left this month | for more free features.

ipatasertib

Showing 1 - 25 of 32

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Triple Negative Breast Cancer Trial in London (Atezolizumab, Ipatasertib, Paclitaxel)

Active, not recruiting
  • Triple Negative Breast Cancer
  • London, United Kingdom
    Barts Health NHS Trust
Aug 10, 2022

Castrate Resistant Prostate Cancer Trial in Chicago, Indianapolis, Hershey (Ipatasertib, Darolutamide, Androgen Deprivation

Recruiting
  • Castrate Resistant Prostate Cancer
  • Ipatasertib
  • +2 more
  • Chicago, Illinois
  • +2 more
Jul 19, 2022

Breast Cancer Trial in Boston (Ipatasertib, Fulvestrant, Aromatase Inhibitor)

Recruiting
  • Breast Cancer
  • Ipatasertib
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Oct 25, 2021

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Sep 28, 2022

NSCLC Stage IV, NSCLC Stage IIIB Trial in United States (Ipatasertib)

Recruiting
  • NSCLC Stage IV
  • NSCLC Stage IIIB
  • Ipatasertib
  • Fairway, Kansas
  • +4 more
Nov 29, 2021

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Metastatic

Not yet recruiting
  • FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • (no location specified)
Sep 13, 2022

Metastatic Breast Cancer Trial in Spain (Ipatasertib, Trastuzumab, Pertuzumab)

Recruiting
  • Metastatic Breast Cancer
  • Ipatasertib
  • +2 more
  • Badalona, Barcelona, Spain
  • +9 more
Jul 23, 2021

Ovarian Tumors Trial in New York (Ipatasertib, Paclitaxel)

Withdrawn
  • Ovarian Neoplasms
  • New York, New York
    Dubin Breast Center
Oct 2, 2020

Triple Negative Breast Cancer Trial in Portugal, Spain (Ipatasertib, Capecitabine, Eribulin)

Recruiting
  • Triple Negative Breast Cancer
  • Ipatasertib
  • +4 more
  • Amadora, Lisboa, Portugal
  • +16 more
Jun 10, 2022

Breast Cancer Trial in Worldwide (Ipatasertib, Paclitaxel, Atezolizumab)

Active, not recruiting
  • Breast Cancer
  • Ipatasertib
  • +4 more
  • Long Beach, California
  • +17 more
Apr 5, 2022

Breast Cancer Trial in Villejuif (Atezolizumab Injection, Ipatasertib, Bevacizumab)

Recruiting
  • Breast Cancer
  • Atezolizumab Injection
  • +4 more
  • Villejuif, France
    Gustave Roussy
Mar 9, 2022

Tumors Trial in Worldwide (5-FU, Docetaxel, Enzalutamide)

Completed
  • Neoplasms
  • San Francisco, California
  • +10 more
Jan 6, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +23 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
  • +1 more
Jul 7, 2022

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +24 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 6, 2022

Early-stage Breast Cancer Trial in Heidelberg (Atezolizumab 1200 mg in 20 ML Injection, Inavolisib, Ipatasertib)

Not yet recruiting
  • Early-stage Breast Cancer
  • Atezolizumab 1200 mg in 20 ML Injection
  • +5 more
  • Heidelberg, Baden-Wuerttemberg, Germany
    National Center for Tumor Diseases
Apr 12, 2022

Gastric Cancer Trial in Worldwide (5-Fluorouracil, Ipatasertib, Leucovorin)

Completed
  • Gastric Cancer
  • Los Angeles, California
  • +33 more
Feb 18, 2022

Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)

Recruiting
  • Breast Cancer
  • Ipatasertib
  • +2 more
  • Bowral, New South Wales, Australia
  • +37 more
Aug 8, 2022

Hepatic Insufficiency Trial in Miami, Knoxville, San Antonio (Ipatasertib)

Completed
  • Hepatic Insufficiency
  • Ipatasertib
  • Miami, Florida
  • +2 more
Nov 15, 2019

Breast Tumors Trial in Worldwide (Ipatasertib, Paclitaxel, Placebo)

Completed
  • Breast Neoplasms
  • Ipatasertib
  • +2 more
  • Fullerton, California
  • +43 more
Feb 18, 2021

Prostate Cancer Trial in Canada (Adavosertib, Savolitinib, Darolutamide)

Recruiting
  • Prostate Cancer
  • Edmonton, Alberta, Canada
  • +10 more
May 9, 2022

Endometrial Cancer Trial in United States (Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib)

Recruiting
  • Endometrial Cancer
  • Atezolizumab - 28 Day Cycle
  • +6 more
  • Duarte, California
  • +13 more
Jun 8, 2022

Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (Binimetinib, Biopsy, Biospecimen Collection)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Locally Advanced Malignant Solid Neoplasm
  • (no location specified)
Sep 29, 2022

Metastatic Prostate Cancer Trial in Worldwide (Ipatasertib, Abiraterone, Placebo)

Active, not recruiting
  • Metastatic Prostate Cancer
  • Ipatasertib
  • +3 more
  • Chandler, Arizona
  • +183 more
Aug 1, 2022

Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer Trial in Worldwide (Giredestrant, Abemaciclib,

Recruiting
  • Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer
  • Duarte, California
  • +27 more
Jul 25, 2022